Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
6,009,091
-
Share change
-
-389,093
-
Total reported value
-
$33,278,940
-
Price per share
-
$5.55
-
Number of holders
-
26
-
Value change
-
-$2,137,110
-
Number of buys
-
10
-
Number of sells
-
15
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2017
As of 30 Sep 2017,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,009,091 shares.
The largest 10 holders included
FMR LLC, JPMORGAN CHASE & CO, ROYCE & ASSOCIATES LP, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, STIFEL FINANCIAL CORP, MILLENNIUM MANAGEMENT LLC, Opus Point Partners Management, LLC, Allianz Asset Management GmbH, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.